Blas Frangione

36.0k total citations · 5 hit papers
355 papers, 27.9k citations indexed

About

Blas Frangione is a scholar working on Molecular Biology, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Blas Frangione has authored 355 papers receiving a total of 27.9k indexed citations (citations by other indexed papers that have themselves been cited), including 247 papers in Molecular Biology, 181 papers in Physiology and 76 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Blas Frangione's work include Alzheimer's disease research and treatments (176 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (98 papers) and Monoclonal and Polyclonal Antibodies Research (74 papers). Blas Frangione is often cited by papers focused on Alzheimer's disease research and treatments (176 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (98 papers) and Monoclonal and Polyclonal Antibodies Research (74 papers). Blas Frangione collaborates with scholars based in United States, United Kingdom and Italy. Blas Frangione's co-authors include Jorge Ghiso, Thomas Wısnıewskı, Frances Prelli, Edward C. Franklin, Eduardo M. Castaño, Berislav V. Zloković, Claudio Soto, Agueda Rostagno, Fabrizio Tagliavini and E. C. Franklin and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Blas Frangione

355 papers receiving 26.7k citations

Hit Papers

Clearance systems in th... 1990 2026 2002 2014 2015 2000 1990 2005 1998 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clearance systems in the brain—implications for Alzheimer disease
    2015 1.3k citations Berislav V. Zloković, Blas Frangione et al. profile →
  2. Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier
    2000 1.2k citations Miguel Calero, Blas Frangione et al. Journal of Clinical Investigation profile →
  3. Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
    1990 1.0k citations Efrat Levy, Ivan Fernandez‐Madrid et al. profile →
  4. Amyloid ion channels: A common structural link for protein-misfolding disease
    2005 831 citations Blas Frangione, Jorge Ghiso et al. Proceedings of the National Academy of Sciences profile →
  5. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy
    1998 742 citations Claudio Soto, Einar M. Sigurdsson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Blas Frangione United States 91 16.0k 15.0k 4.3k 3.0k 2.8k 355 27.9k
Robert W. Mahley United States 116 12.5k 0.8× 17.2k 1.1× 2.3k 0.5× 1.4k 0.5× 4.0k 1.4× 303 44.3k
David B. Teplow United States 93 20.6k 1.3× 20.2k 1.3× 3.4k 0.8× 1.4k 0.5× 3.4k 1.2× 217 33.1k
Todd E. Golde United States 94 18.8k 1.2× 14.2k 0.9× 5.4k 1.3× 3.2k 1.1× 5.7k 2.0× 314 32.1k
William M. Pardridge United States 103 6.5k 0.4× 17.2k 1.1× 6.0k 1.4× 1.8k 0.6× 6.3k 2.2× 495 40.4k
Takaomi C. Saido Japan 98 19.6k 1.2× 16.3k 1.1× 6.6k 1.5× 2.3k 0.8× 8.2k 2.9× 504 36.1k
Mathias Jucker Germany 73 13.8k 0.9× 9.8k 0.7× 7.0k 1.6× 2.8k 0.9× 4.5k 1.6× 179 22.5k
Catriona McLean Australia 69 6.4k 0.4× 7.1k 0.5× 2.5k 0.6× 2.9k 1.0× 2.4k 0.9× 471 19.5k
Jesús Ávila Spain 95 13.9k 0.9× 16.1k 1.1× 4.4k 1.0× 2.5k 0.8× 10.1k 3.6× 650 33.7k
Bruce A. Yankner United States 57 12.1k 0.8× 13.5k 0.9× 2.7k 0.6× 1.9k 0.6× 5.6k 2.0× 79 26.4k
Karl H. Weisgraber United States 87 9.3k 0.6× 12.5k 0.8× 1.4k 0.3× 925 0.3× 2.8k 1.0× 237 28.3k

Countries citing papers authored by Blas Frangione

Since Specialization
Citations

This map shows the geographic impact of Blas Frangione's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blas Frangione with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blas Frangione more than expected).

Fields of papers citing papers by Blas Frangione

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blas Frangione. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blas Frangione. The network helps show where Blas Frangione may publish in the future.

Co-authorship network of co-authors of Blas Frangione

This figure shows the co-authorship network connecting the top 25 collaborators of Blas Frangione. A scholar is included among the top collaborators of Blas Frangione based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blas Frangione. Blas Frangione is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wısnıewskı, Thomas, Einar M. Sigurdsson, Pièrre Aucouturier, & Blas Frangione. (2003). Conformation as Therapeutic Target in the Prionoses and Other Neurodegenerative Conditions. Humana Press eBooks. 59. 223–236. 5 indexed citations
2.
Sigurdsson, Einar M., David R. Brown, Maki Daniels, et al.. (2002). Immunization Delays the Onset of Prion Disease in Mice. American Journal Of Pathology. 161(1). 13–17. 150 indexed citations
3.
Sigurdsson, Einar M., Henrieta Scholtzova, Pankaj Mehta, Blas Frangione, & Thomas Wısnıewskı. (2001). Immunization with a Nontoxic/Nonfibrillar Amyloid-β Homologous Peptide Reduces Alzheimer's Disease-Associated Pathology in Transgenic Mice. American Journal Of Pathology. 159(2). 439–447. 210 indexed citations
4.
Ghiso, Jorge, Rubén Vidal, Agueda Rostagno, et al.. (2000). A Newly Formed Amyloidogenic Fragment due to a Stop Codon Mutation Causes Familial British Dementia. Annals of the New York Academy of Sciences. 903(1). 129–137. 34 indexed citations
5.
Chyan, Yau‐Jan, et al.. (2000). An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. Journal of Neural Transmission. 107(2). 203–231. 214 indexed citations
6.
Mačkić, Jasmina B., Monique F. Stins, J. Gordon McComb, et al.. (1998). Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer.. Journal of Clinical Investigation. 102(4). 734–743. 200 indexed citations
7.
Castaño, Eduardo M., Frances Prelli, Claudio Soto, et al.. (1996). The length of Amyloid-β in Hereditary Cerebral Hemorrhage with Amyloidosis, Dutch Type. Journal of Biological Chemistry. 271(50). 32185–32191. 73 indexed citations
8.
Sanan, David A., Karl H. Weisgraber, Stephen J. Russell, et al.. (1994). Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.. Journal of Clinical Investigation. 94(2). 860–869. 335 indexed citations
9.
Bugiani, Orso, Giorgio Giaccone, Laura Verga, et al.. (1990). Alzheimer patients and Down patients: Abnormal presynaptic terminals are related to cerebral preamyloid deposits. Neuroscience Letters. 119(1). 56–59. 45 indexed citations
10.
Levy, Efrat, Matti Haltia, Ivan Fernandez‐Madrid, et al.. (1990). Mutation in gelsolin gene in Finnish hereditary amyloidosis.. The Journal of Experimental Medicine. 172(6). 1865–1867. 120 indexed citations
11.
Fernández, J, et al.. (1989). Structural and idiotypic characterization of the L chains of human IgM autoantibodies with different specificities.. The Journal of Immunology. 142(9). 3158–3163. 30 indexed citations
12.
Mihaesco, Edith, et al.. (1988). Protein Rou. A human IgA hybrid.. The Journal of Immunology. 140(4). 1236–1238. 3 indexed citations
13.
Gorevic, Peter D., Priscilla C. Munoz, Terence T. Casey, et al.. (1986). Polymerization of intact beta 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis.. Proceedings of the National Academy of Sciences. 83(20). 7908–7912. 127 indexed citations
14.
Gorevic, Peter D., Frances Prelli, & Blas Frangione. (1985). [1] Immunoglobulin G (IgG). Methods in enzymology on CD-ROM/Methods in enzymology. 116. 3–25. 29 indexed citations
15.
Prelli, Frances, Mordechai Pras, & Blas Frangione. (1985). The primary structure of human tissue amyloid P component from a patient with primary idiopathic amyloidosis.. Journal of Biological Chemistry. 260(24). 12895–12898. 42 indexed citations
16.
Pons‐Estel, Bernardo A., Fernando Goñi, Alan Solomon, & Blas Frangione. (1984). Sequence similarities among kappa IIIb chains of monoclonal human IgM kappa autoantibodies.. The Journal of Experimental Medicine. 160(3). 893–904. 50 indexed citations
17.
Cohen, David H., et al.. (1983). AA protein-related renal amyloidosis in drug addicts.. PubMed. 112(2). 195–9. 35 indexed citations
18.
Cohen, David H., Helen Feiner, O Jensson, & Blas Frangione. (1983). Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis (HCHWA) is related to the gastroentero-pancreatic neuroendocrine protein, gamma trace.. The Journal of Experimental Medicine. 158(2). 623–628. 150 indexed citations
19.
Alexander, Alice, Michael Steinmetz, Denis Barritault, et al.. (1982). gamma Heavy chain disease in man: cDNA sequence supports partial gene deletion model.. Proceedings of the National Academy of Sciences. 79(10). 3260–3264. 54 indexed citations
20.
Wolfenstein‐Todel, Carlota, Eduardo Méndez, Frances Prelli, Blas Frangione, & E. C. Franklin. (1974). Disulfide Bridges of Human Immunoglobulins A1 and A2. PubMed. 45(0). 257–261. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert W. Mahley Breakdown of academic impact, for papers by David B. Teplow Breakdown of academic impact, for papers by Todd E. Golde Breakdown of academic impact, for papers by William M. Pardridge Breakdown of academic impact, for papers by Takaomi C. Saido Breakdown of academic impact, for papers by Mathias Jucker Breakdown of academic impact, for papers by Catriona McLean Breakdown of academic impact, for papers by Jesús Ávila Breakdown of academic impact, for papers by Bruce A. Yankner Breakdown of academic impact, for papers by Karl H. Weisgraber
Rankless by CCL
2026